Cancer and ischemic events, cardiac-arrest survival, alcohol, PCSK9i costs, and an ESC preview are discussed by Dr John Mandrola in this week's podcast.

Lipid-lowering therapy, off-pump bypass, nonobstructive CAD, the obesity paradox, and ACS treatment in the elderly are discussed in this week's podcast.

Statins after stroke, MI definition, dietary sodium, gene editing, and a potential new way to image coronaries are the topics discussed by Dr John Mandrola in this week's podcast.

Behavior counseling in type 2 diabetes, FDA regulation of tobacco, cuff BP readings, smoking cessation, and CV genetics are discussed this week.

Obstructive sleep apnea, changes in diet, AF ablation, statin rechallenge, and prediabetes are covered in this week's podcast.

Declining rates of sudden death in patients with heart failure, a new indication for TAVR, coffee (again), and counseling the well are the topics discussed by Dr Mandrola in this week’s podcast.

ICD use, sudden cardiac death, BMI and obesity, and off-label implantation of transcatheter aortic valves are discussed in this week's podcast.

Insulin-Statin-PCSK9 linkage, QOL on warfarin, ticagrelor adherence, cardio-protection for Breast CA Rx, Brugada Syndrome and AF ablation as a placebo are discussed by Dr Mandrola in this week's podcast.

The LEADER diabetes trial, remote-monitoring preferences, avoidable stroke burden, air pollution, and two AF ablation trials (FIRE and ICE secondary analysis and ICE-T) are reviewed this week.

Potential risk for cancer diagnosis after AF, the merits of low-Na policies, Tai Chi effects on BP, and the unseen bias of medical organizations in guidelines are discussed in this week's podcast.